Market closed

Harmony Biosciences/$HRMY

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Harmony Biosciences

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

Ticker

$HRMY
Trading on

Industry

Pharmaceuticals

Employees

246

HRMY Metrics

BasicAdvanced
$1.9B
Market cap
16.18
P/E ratio
$2.11
EPS
0.73
Beta
-
Dividend rate
$1.9B
0.73
$39.02
$28.14
977K
3.239
3.05
28.269
31.039
9.69%
12.84%
22.75%
16.18
2.857
3.26
4.07
10.008
25.83%
-14.80%
36.09%
120.67%

What the Analysts think about HRMY

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Harmony Biosciences stock.

HRMY Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HRMY Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HRMY

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Harmony Biosciences stock?

Harmony Biosciences (HRMY) has a market cap of $1.9B as of November 24, 2024.

What is the P/E ratio for Harmony Biosciences stock?

The price to earnings (P/E) ratio for Harmony Biosciences (HRMY) stock is 16.18 as of November 24, 2024.

Does Harmony Biosciences stock pay dividends?

No, Harmony Biosciences (HRMY) stock does not pay dividends to its shareholders as of November 24, 2024.

When is the next Harmony Biosciences dividend payment date?

Harmony Biosciences (HRMY) stock does not pay dividends to its shareholders.

What is the beta indicator for Harmony Biosciences?

Harmony Biosciences (HRMY) has a beta rating of 0.73. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.